-
Signature
-
/s/ Chad Porter, by power of attorney
-
Stock symbol
-
BSTG
-
Transactions as of
-
Nov 26, 2021
-
Transactions value $
-
$0
-
Form type
-
3
-
Date filed
-
11/30/2021, 05:10 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
holding |
BSTG |
Common Stock |
|
|
|
|
|
23.1K |
Nov 26, 2021 |
Direct |
|
holding |
BSTG |
Common Stock |
|
|
|
|
|
16.5K |
Nov 26, 2021 |
2018 Biostage GRAT |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
BSTG |
Stock Option (right to buy) |
|
|
|
|
|
|
Nov 26, 2021 |
Common Stock |
1.25K |
$33.80 |
Direct |
F1 |
holding |
BSTG |
Stock Option (right to buy) |
|
|
|
|
|
|
Nov 26, 2021 |
Common Stock |
1.25K |
$36.80 |
Direct |
F1 |
holding |
BSTG |
Stock Option (right to buy) |
|
|
|
|
|
|
Nov 26, 2021 |
Common Stock |
36.3K |
$85.80 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Interim Chief Executive Officer